CY1125361T1 - Φαρμακευτικο παρασκευασμα υδατανθρακων για θεραπευτικη χρηση - Google Patents
Φαρμακευτικο παρασκευασμα υδατανθρακων για θεραπευτικη χρησηInfo
- Publication number
- CY1125361T1 CY1125361T1 CY20211100863T CY211100863T CY1125361T1 CY 1125361 T1 CY1125361 T1 CY 1125361T1 CY 20211100863 T CY20211100863 T CY 20211100863T CY 211100863 T CY211100863 T CY 211100863T CY 1125361 T1 CY1125361 T1 CY 1125361T1
- Authority
- CY
- Cyprus
- Prior art keywords
- carbohydrates
- pharmaceutical preparation
- therapeutic use
- carbohydrate
- cdg type
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Abstract
Η φανέρωση παρέχει μεθόδους για παρασκευή θεραπειών υποκατάστασης υδατανθράκων (CRT) που περιλαμβάνουν νανοφορείς υδατανθράκων και γλυκολιπίδια για φαρμακευτική διανομή στο εσωτερικό των κυττάρων, ενδοπλασματικό δίκτυο, και Golgi για αντιμετώπιση νόσων CDG τύπου Ι και CDG τύπου II όπως επίσης και άλλων μεταβολικών διαταραχών.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361878591P | 2013-09-16 | 2013-09-16 | |
PCT/US2014/055921 WO2015053910A2 (en) | 2013-09-16 | 2014-09-16 | Pharmaceutical preparation of carbohydrates for therapeutic use |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1125361T1 true CY1125361T1 (el) | 2023-03-24 |
Family
ID=52813726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20211100863T CY1125361T1 (el) | 2013-09-16 | 2021-10-05 | Φαρμακευτικο παρασκευασμα υδατανθρακων για θεραπευτικη χρηση |
Country Status (13)
Country | Link |
---|---|
US (5) | US20160228364A1 (el) |
EP (2) | EP3046537B1 (el) |
CY (1) | CY1125361T1 (el) |
DK (1) | DK3046537T3 (el) |
ES (1) | ES2892314T3 (el) |
HR (1) | HRP20211564T1 (el) |
HU (1) | HUE056624T2 (el) |
LT (1) | LT3046537T (el) |
PL (1) | PL3046537T3 (el) |
PT (1) | PT3046537T (el) |
RS (1) | RS62641B1 (el) |
SI (1) | SI3046537T1 (el) |
WO (1) | WO2015053910A2 (el) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20212366A1 (es) * | 2019-03-29 | 2021-12-21 | Glycomine Inc | Formulaciones liposomales y metodos de uso y preparacion de las mismas |
US11058637B1 (en) * | 2020-11-25 | 2021-07-13 | King Abdulaziz University | Surface-modified emulsomes for intranasal delivery of drugs |
WO2023225102A1 (en) * | 2022-05-18 | 2023-11-23 | Glycomine, Inc. | Continuous flow methods for producing mannose-1-phosphate, polymorphs of mannose-1-phosphate, and compositions and uses related thereto |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5013556A (en) * | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US7189705B2 (en) * | 2000-04-20 | 2007-03-13 | The University Of British Columbia | Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers |
US7011845B2 (en) * | 2000-05-09 | 2006-03-14 | Mcp Hahnemann University | β-glucans encapsulated in liposomes |
WO2004103510A2 (en) * | 2003-05-14 | 2004-12-02 | The Regents Of The University Of Colorado | Methods and apparatus using electrostatic atomization to form liquid vesicles |
FR2897779B1 (fr) | 2006-02-24 | 2009-04-17 | Orphan Europ Sarl | Manossyl-1 phosphates, procede de preparation et utilisation en therapeutique, notamment vis-a-vis dy syndrome cdg-la |
WO2009118658A2 (en) | 2008-03-26 | 2009-10-01 | University Of Oxford | Endoplasmic reticulum targeting liposomes |
US20120135064A1 (en) * | 2009-05-27 | 2012-05-31 | Northeastern University | Conjugated nanodelivery vehicles |
US20110200582A1 (en) | 2009-12-23 | 2011-08-18 | Novartis Ag | Lipids, lipid compositions, and methods of using them |
US20110257233A1 (en) | 2010-03-19 | 2011-10-20 | Sanford-Burnham Medical Research Institute | Benzoisothiazolones as inhibitors of phosphomannose isomerase |
CA2807141C (en) * | 2010-07-31 | 2019-02-26 | The Scripps Research Institute | Compositions and methods for inducing immune tolerance |
-
2014
- 2014-09-16 DK DK14851464.9T patent/DK3046537T3/da active
- 2014-09-16 HU HUE14851464A patent/HUE056624T2/hu unknown
- 2014-09-16 LT LTEPPCT/US2014/055921T patent/LT3046537T/lt unknown
- 2014-09-16 ES ES14851464T patent/ES2892314T3/es active Active
- 2014-09-16 US US15/022,194 patent/US20160228364A1/en not_active Abandoned
- 2014-09-16 SI SI201431883T patent/SI3046537T1/sl unknown
- 2014-09-16 PL PL14851464T patent/PL3046537T3/pl unknown
- 2014-09-16 WO PCT/US2014/055921 patent/WO2015053910A2/en active Application Filing
- 2014-09-16 PT PT14851464T patent/PT3046537T/pt unknown
- 2014-09-16 HR HRP20211564TT patent/HRP20211564T1/hr unknown
- 2014-09-16 RS RS20211212A patent/RS62641B1/sr unknown
- 2014-09-16 EP EP14851464.9A patent/EP3046537B1/en active Active
- 2014-09-16 EP EP21185152.2A patent/EP3954360A3/en active Pending
-
2017
- 2017-10-19 US US15/788,591 patent/US10449149B2/en active Active
-
2019
- 2019-09-11 US US16/568,098 patent/US11045419B2/en active Active
-
2021
- 2021-05-21 US US17/327,241 patent/US20220110871A1/en not_active Abandoned
- 2021-10-05 CY CY20211100863T patent/CY1125361T1/el unknown
-
2023
- 2023-03-30 US US18/193,328 patent/US20240082155A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2015053910A3 (en) | 2015-06-18 |
HRP20211564T1 (hr) | 2022-01-21 |
US20160228364A1 (en) | 2016-08-11 |
EP3954360A3 (en) | 2022-06-01 |
US20180036239A1 (en) | 2018-02-08 |
US11045419B2 (en) | 2021-06-29 |
DK3046537T3 (da) | 2021-10-11 |
EP3046537B1 (en) | 2021-07-14 |
US10449149B2 (en) | 2019-10-22 |
PT3046537T (pt) | 2021-10-07 |
US20240082155A1 (en) | 2024-03-14 |
US20220110871A1 (en) | 2022-04-14 |
EP3046537A2 (en) | 2016-07-27 |
EP3046537A4 (en) | 2017-04-19 |
HUE056624T2 (hu) | 2022-02-28 |
US20200246266A1 (en) | 2020-08-06 |
LT3046537T (lt) | 2021-12-10 |
PL3046537T3 (pl) | 2022-01-31 |
RS62641B1 (sr) | 2021-12-31 |
EP3954360A2 (en) | 2022-02-16 |
ES2892314T3 (es) | 2022-02-03 |
SI3046537T1 (sl) | 2022-01-31 |
WO2015053910A2 (en) | 2015-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1125361T1 (el) | Φαρμακευτικο παρασκευασμα υδατανθρακων για θεραπευτικη χρηση | |
CY1121348T1 (el) | Mrna θεραπεια για την θεραπευτικη αγωγη οφθαλμικων ασθενειων | |
CA2895175C (en) | Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway | |
MY174727A (en) | Stable, protracted glp-1/glucagon receptor co-agonists for medical use | |
BR112016009077A2 (pt) | Formulações lipídicas para fornecimento de rna mensageiro | |
MY188139A (en) | Sodium channel modulators for the treatment of pain | |
MY165888A (en) | Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation | |
BR112014030404A2 (pt) | proteína de fusão hgh-xten e seu uso no tratamento da deficiência de hormônio do crescimento | |
NZ715797A (en) | Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation | |
AR095338A1 (es) | Método de tratamiento no tóxico para la abstinencia de drogas | |
EP4360621A3 (en) | Formulations of bendamustine | |
MD20150120A2 (ro) | Tratamentul bolilor neurodegenerative şi miopatice de agregare proteică prin administrarea parenterală a trehalozei | |
MX2017004772A (es) | Composiciones y métodos para la administración fisiológica utilizando cannabidiol. | |
EA201391689A1 (ru) | Система доставки лекарственного средства | |
AR098832A1 (es) | Uso de laquinimod para retrasar la progresión de la enfermedad de huntington | |
MX2015007731A (es) | Formulacion farmaceutica que comprende ciclesonida. | |
MX362485B (es) | Nuevos inhibidores de rock. | |
MX2021011876A (es) | Formulaciones liposomicas y metodos de uso y preparacion de las mismas. | |
WO2014184726A3 (en) | Compounds and their use in therapy | |
PH12016501347A1 (en) | Filters for infusion sets | |
BR112017007102A2 (pt) | uso de um medicamento no tratamento de patologias da córnea, composição oftálmica para uso de um medicamento no tratamento de doenças da córnea e método para preparar a composição oftálmica | |
NZ713490A (en) | Oral suspension for treating eosinophilic esophagitis | |
EA201992463A1 (ru) | Система доставки лекарственного средства | |
UA63647U (ru) | Способ лечения алкогольной зависимости | |
UA113061C2 (xx) | Система доставки лікарського засобу |